Stattic STAT inhibition attenuates FUNDC1 dependent mitochondrial dysfunction in septic cardiomyocytes
Copy code to add this image to your page
Sepsis-induced myocardial dysfunction (SIMD) represents a severe clinical impairment driven by systemic inflammation and cellular metabolic destabilization. At the molecular center of this inflammatory pathology lies the signal transducer and activator of transcription 3 (STAT3) axis. Activated downstream of interleukin-6 (IL-6) cytokines, canonical STAT3 signaling triggers intracellular transcriptional programs that govern cellular stress responses. In myocardial tissue under septic conditions, inflammatory stimuli such as lipopolysaccharide (LPS) cause elevated STAT3 phosphorylation, driving aberrant expression of downstream target genes. Among these transcriptional targets, FUN13 domain-containing protein 1 (FUNDC1) functions as an outer mitochondrial membrane protein that physically tethers mitochondria to the endoplasmic reticulum, creating structural junctions termed mitochondria-associated endoplasmic reticulum membranes (MAMs). Direct molecular characterization through protein domain and family classification resources highlights how structural protein domains govern these inter-organelle interactions. Pathological induction of FUNDC1 accelerates excessive MAM formation, precipitating aberrant calcium ion transfer from the sarcoplasmic reticulum into the mitochondrial matrix.
Pharmacological evaluation of this pathway relies on small-molecule probes capable of disrupting STAT3 dimerization and function. The small-molecule inhibitor Stattic selective STAT3 engagement acts as a precise biochemical tool to dissect this signaling axis in cardiomyocyte models. In cultured H9c2 cardiomyocytes subjected to LPS exposure, administration of Stattic suppresses STAT3 phosphorylation and downstream target gene expression. Specifically, STAT3 inhibition directly attenuates LPS-induced transcript and protein levels of FUNDC1. Beyond transcriptional control of FUNDC1, Stattic STAT target intervention suppresses phosphorylation of the inositol 1,4,5-trisphosphate receptor (IP3R) at the Ser1756 residue, an essential event regulating calcium efflux at the endoplasmic reticulum membrane. Through the dual reduction of FUNDC1 accumulation and IP3R phosphorylation, Stattic destabilizes excessive physical and functional coupling between the endoplasmic reticulum and mitochondria in septic cardiac cells.
Disruption of structural MAM assemblies by Stattic yields notable secondary effects on cellular calcium handling and mitochondrial energetics. Sepsis normally provokes intracellular Ca2+ overload, mediated by altered activity of major calcium channels including L-type calcium channel subunit Cav1.2 and ryanodine receptor 2 (RyR2). Treatment with Stattic normalizes the expression of Cav1.2 and RyR2 in LPS-stimulated H9c2 cells, limiting pathological cytosolic calcium accumulation. Concurrently, attenuation of mitochondrial calcium influx preserves the mitochondrial membrane potential and prevents the collapse of cellular ATP production. Mitigation of excessive calcium loading further blunts mitochondrial ROS generation and halts pathologically accelerated mitophagy and organellar fragmentation. These biochemical observations establish that targeted inhibition of STAT3 signaling via Stattic mitigates mitochondrial dysfunction in septic cardiomyocytes by restricting FUNDC1-mediated MAM structural assembly.
Pharmacological Interventions in Septic Cardiomyocyte Mitochondrial Homeostasis
Copy code to add this image to your page
Stattic targets STAT3 activity to inhibit STAT3 phosphorylation and downstream transcription of FUNDC1 in septic cardiomyocytes. By suppressing FUNDC1 expression and IP3R phosphorylation at Ser1756, Stattic blocks mitochondria-associated endoplasmic reticulum membrane formation. This reduction attenuates intracellular Ca2+ overload, downregulates calcium signaling proteins Cav1.2 and RyR2, restores mitochondrial membrane potential and ATP production, mitigates mitochondrial fragmentation and excessive mitophagy, and suppresses reactive oxygen species generation during lipopolysaccharide challenge.
Attenuated FUNDC1 Transcription Reduces Endoplasmic Reticulum Contact Points
LPS administration to H9c2 cardiomyocytes markedly increases STAT3 activity. This transcriptional activity elevates FUNDC1 expression within hours. Stattic administration directly interrupts this transcript activation. In vitro assays demonstrate a dose-dependent reduction in nuclear STAT3 occupancy at the FUNDC1 promoter region. Reduced FUNDC1 protein abundance limits physical ER-mitochondria tethering. Consequently, structural MAM contact sites drop significantly under Stattic STAT targeting conditions. Phosphorylation of IP3R at Ser1756 concurrently decreases upon drug treatment. Sarcoplasmic reticulum calcium leaks decline accordingly. These structural alterations prevent excessive direct calcium flux into the mitochondrial matrix.
Normalizing Calcium Transport Restores Membrane Potential and ATP Production
Pathological calcium entry alters cardiac electrophysiology and bioenergetics. Intracellular calcium overload was observed in untreated LPS-exposed H9c2 cardiomyocytes. Stattic therapy reversed this ion accumulation. Expression levels of the primary calcium influx channels Cav1.2 and RyR2 returned toward baseline values in treated groups. Reduced ionic stress protected mitochondrial integrity. The mitochondrial membrane potential, measured via fluorescent indicator dyes, stabilized rapidly following treatment. Cellular ATP synthesis rose significantly compared to untreated septic controls. The selectivity margin remained intact throughout the tested concentration range.
Suppression of Reactive Species Mitigates Mitophagy and Organelle Disruption
Uncontrolled mitochondrial calcium influx fuels reactive oxygen species generation. In septic H9c2 cells, ROS accumulation damaged structural proteins and lipids. Stattic STAT intervention effectively suppressed cellular ROS levels. Mitigating oxidative stress preserved mitochondrial network morphology. High-resolution imaging revealed a marked reduction in mitochondrial fragmentation following STAT3 inhibition. Excessive autophagic degradation of mitochondria, measured via mitophagy marker conversion, decreased toward physiological baseline levels. These experimental findings define a clear pharmacodynamic boundary for STAT3 inhibition in preserving cardiomyocyte organelle structure under septic stress.